Insights

DISCOVER

COMPANY

Survey

SURVEY

Consulting

COUNSULTING

Create New Account

Book discovery call

Nebulizers Global Market Report 2020-30: Covid 19 Implications and Growth

Region:Global

Product Code:7626

Download Sample Report

Published On

April 2020

Total pages

200 Table of Content

Market Overview
Scope Of The Report
Product covered
Table Of Content
Research Methodology
FAQs

Download Sample Report

About the Report

Major players in the nebulizer devices market are Agilent Technologies, Becton Dickinson and Company, Koninklijke Philips N.V., Omron Corporation, Covidien plc, GE Healthcare Ltd., Allied Healthcare Products, Inc, Briggs Healthcare, PARI Pharma, and GF Health Products, Inc.

The global nebulizers market is expected to grow from USD 0.8 billion in 2019 to about USD 1.7 billion in 2020 as these devices are used for respiratory infection treatment including mild Covid-19. The market is expected to stabilize and reach USD 1.3 billion at a CAGR of 10.9% through 2023.

The current Covid-19 pandemic has resulted in a surge in demand for nebulizers. There has been an increased use of albuterol inhalers in hospitals for Covid-19 and suspected Covid-19 patients to help with respiratory issues. This is mainly because respiratory viruses are the most common trigger for asthma exacerbations.

The nebulizer devices market consists of sales of nebulizers used in respiratory care for patients with respiratory diseases including asthma, cystic fibrosis and COPD. The sales consists of revenues generated by establishments that are primarily engaged in the manufacturing of breath actuated and vented pneumatic nebulizers, portable and standalone ultrasonic nebulizers, and static and vibrating type mesh nebulizers.

Nebulizer therapy requires a device that repeatedly and quickly delivers sufficient drug with minimal wastage, to the site of action. However, during nebulization aerosol with a smaller particle size are inhaled or delivered to the site of action while large particles return to reservoir feeding tube. Also, some of the drug aerosols settle on the walls of the baffle. This drug is retained within the nebulizer, (also called as residual drug or dead volume) or released into environment during expiration. This results in drug wastage. Drug wastage during exhalation is therefore challenging the growth of nebulizer market. The development of technically advanced novel nebulizers is however expected to reduce drug wastage and improve delivery efficacy.

To overcome the challenges of existing nebulizers, advanced novel nebulizers are coming into existence. The technologically advanced nebulizers including breath-enhanced, breath-actuated, and vibrating mesh nebulizers decrease the amount of drug lost during exhalation while increasing the efficiency of drug delivery. For instance, the advanced and efficient vibrating mesh nebulizer has an electronic indicator that shows when the patient is breathing appropriately and only then, it releases the dose. A vibrating mesh nebulizer coupled with an adaptive aerosol delivery software adjusts the aerosol emission based on the breathing pattern of the patient, which reduces drug loss and increases the inhaled mass. The latest and advanced nebulizers increase the output rate which in turn will decrease the administration time.

Rising geriatric population across the globe is expected to increase the usage of respiratory care devices including nebulizers over the forecast period. For instance, according to the World Health Organization (WHO), by 2050, the world's population aged 60 years and older is expected to total 2 billion, up from 900 million in 2015. As of 2018, 125 million people are aged 80 years or older. In the United States, according to the Population Reference Bureau report, the number of Americans aged 65 and older is projected to nearly double from 52 million in 2018 to 95 million by 2060. Elderly people are more susceptible to respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD), sleep apnea, and the recent pandemic COVID-19 for many factors including gradual decline of immune function. Therefore, rise in geriatric population is anticipated to propel the nebulizer market growth.

Scope of the Report

Products

1) By Type: Pneumatic Nebulizer; Ultrasonic Nebulizer; Mesh Nebulizer; 2) By Application: COPD; Cystic Fibrosis; Asthma; Others

Companies

Agilent Technologies; Becton Dickinson and Company; Koninklijke Philips N.V.; Omron Corporation; Covidien plc; GE Healthcare Ltd.; Allied Healthcare Products, Inc; Briggs Healthcare; PARI Pharma; GF Health Products, Inc.; Medline Industries Inc.; Invacare Corporation

1. Executive Summary

2. Nebulizers Market Characteristics

3. Nebulizers Market Size And Growth

3.1. Global Nebulizers Historic Market, 2015-2019, USD Billion

3.1.1. Drivers Of The Market

3.1.2. Restraints On The Market

3.2. Global Nebulizers Forecast Market, 2019-2023F, 2025F, 2030F, USD Billion

3.2.1. Drivers Of The Market

3.2.2. Restraints On the Market

4. Nebulizers Market Segmentation

4.1. Global Nebulizers Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Pneumatic Nebulizer

Ultrasonic Nebulizer

Mesh Nebulizer

4.2. Global Nebulizers Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

COPD

Cystic Fibrosis

Asthma

Others

5. Nebulizers Market Regional And Country Analysis

5.1. Global Nebulizers Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

5.2. Global Nebulizers Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

6. Asia-Pacific Nebulizers Market

6.1. Asia-Pacific Nebulizers Market Overview

6.2. Asia-Pacific Nebulizers Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

7. China Nebulizers Market

7.1. China Nebulizers Market Overview

7.2. China Nebulizers Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,USD Billion

8. India Nebulizers Market

8.1. India Nebulizers Market Overview

8.2. India Nebulizers Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

9. Japan Nebulizers Market

9.1. Japan Nebulizers Market Overview

9.2. Japan Nebulizers Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

10. Australia Nebulizers Market

10.1. Australia Nebulizers Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

11. Indonesia Nebulizers Market

11.1. Indonesia Nebulizers Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

12. South Korea Nebulizers Market

12.1. South Korea Nebulizers Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

13. Western Europe Nebulizers Market

13.1. Western Europe Nebulizers Market Overview

13.2. Western Europe Nebulizers Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

14. UK Nebulizers Market

14.1. UK Nebulizers Market Overview

14.2. UK Nebulizers Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

15. Germany Nebulizers Market

15.1. Germany Nebulizers Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

16. France Nebulizers Market

16.1. France Nebulizers Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

17. Eastern Europe Nebulizers Market

17.1. Eastern Europe Nebulizers Market Overview

17.2. Eastern Europe Nebulizers Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

18. Russia Nebulizers Market

18.1. Russia Nebulizers Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

19. North America Nebulizers Market

19.1. North America Nebulizers Market Overview

19.2. North America Nebulizers Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

20. USA Nebulizers Market

20.1. USA Nebulizers Market Overview

20.2. USA Nebulizers Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

21. South America Nebulizers Market

21.1. South America Nebulizers Market Overview

21.2. South America Nebulizers Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

22. Brazil Nebulizers Market

22.1. Brazil Nebulizers Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

23. Middle East Nebulizers Market

23.1. Middle East Nebulizers Market Overview

23.2. Middle East Nebulizers Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

24. Africa Nebulizers Market

24.1. Africa Nebulizers Market Overview

24.2. Africa Nebulizers Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

25. Nebulizers Market Competitive Landscape And Company Profiles

25.1. Nebulizers Market Competitive Landscape

25.2. Nebulizers Market Company Profiles

25.2.1. Agilent Technologies

25.2.1.1. Overview

25.2.1.2. Products and Services

25.2.1.3. Strategy

25.2.1.4. Financial Performance

25.2.2. Becton Dickinson and Company

25.2.2.1. Overview

25.2.2.2. Products and Services

25.2.2.3. Strategy

25.2.2.4. Financial Performance

25.2.3. Koninklijke Philips N.V.

25.2.3.1. Overview

25.2.3.2. Products and Services

25.2.3.3. Strategy

25.2.3.4. Financial Performance

25.2.4. Omron Corporation

25.2.4.1. Overview

25.2.4.2. Products and Services

25.2.4.3. Strategy

25.2.4.4. Financial Performance

25.2.5. Covidien plc

25.2.5.1. Overview

25.2.5.2. Products and Services

25.2.5.3. Strategy

25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Nebulizers Market

27. Nebulizers Market Trends And Strategies

28. Nebulizers Market Future Outlook and Potential Analysis

29. Appendix

29.1. Abbreviations

29.2. Currencies

29.3. Research Inquiries

29.4. The Business Research Company

29.5. Copyright And Disclaimer

Research Methodology

Why Buy From Us?

Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository

150+ Consulting project a year

100+ Analysts

8000+ Client Queries in 2022